Le Lézard
Classified in: Business
Subject: STOCK/OTHER MARKET NEWS

CSE: 2018-0529 ? New Listing ? Izotropic Corporation (IZO)


TORONTO, May 30, 2018 (GLOBE NEWSWIRE) --

The common shares of Izotropic Corporation have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

The Company is engaged in the commercialization of proprietary diagnostic products for breast cancer. Its business strategy is to complete the commercial development of 360 degree, true 3D breast imaging technology for early diagnosis of breast cancer. The Company holds a license under a license agreement to make, have made, use, offer for sale, import, and sell products and services and to practice processes and methods in the field of human diagnostics and therapeutics in the United States and any other countries where approvals are granted or where patent rights may exist in the future with respect to certain licensed patent rights.

________________________

Les actions ordinaires de Izotropic Corporation ont été approuvées pour inscription à la cote du CSE.

Les documents d'inscription et de divulgation seront disponibles sur www.thecse.com à la date de négociation.

La Société est engagée dans la commercialisation de produits de diagnostic exclusifs pour le cancer du sein. Sa stratégie commerciale consiste à compléter le développement commercial de la technologie d'imagerie mammaire 3D à 360 degrés pour le diagnostic précoce du cancer du sein. La Société détient une licence en vertu d'un contrat de licence pour fabriquer, fabriquer, utiliser, mettre en vente, importer et vendre des produits et services et pour pratiquer des procédés et méthodes dans le domaine du diagnostic et de la thérapeutique humaine aux États-Unis et dans tout autre pays lorsque des approbations sont accordées ou lorsque des droits de brevet peuvent subsister à l'avenir en ce qui concerne certains droits de brevet sous licence.

  
Issuer/Émetteur:Izotropic Corporation
Security Type/Titre:Common Shares/Actions ordinaires
Symbol(s)/Symbole(s):IZO
Number of securities issued and outstanding/ Titres émis et en circulation:20 499 999
Number of Securities reserved for issuance/ Titres réservés pour émission:12 199 999
CSE Sector/Catégorie:Life Sciences/ Sciences biologiques
CUSIP:46604F 10 9
ISIN:CA 46604F 10 9 9
Boardlot/Quotité:500
IPO Price/Prix:$0.10/0,10 $
Agents:Chippingham Financial Group Limited
Trading Currency/Monnaie de négociation:CDN$/$CDN
Listing Date/Date de l'inscription:Le 31 mai/May 2018
Trading Date/Date de negociation:Le 4 juin/June 2018
Other Exchanges/Autres marches:N/A
Fiscal Year end /Clôture de l'exercice financier:April 30/Le 30 avril
Transfer Agent/Agent des transferts:Odyssey Trust Company
  

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: [email protected]

Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse:  [email protected]


These press releases may also interest you

at 03:57
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of those who held the common stock of Northern Genesis Acquisition Corp. n/k/a The Lion Electric Company as of the record date of March...

at 03:44
Bitrue, a leading cryptocurrency exchange serving over 10 million users globally, announces a focus on user behavior analysis to further develop the utility of its native token, Bitrue Coin (BTR). "Understanding how our users interact with BTR is...

at 03:04
Policybazaar, India's leading online insurance marketplace, is witnessing a significant increase in non-resident Indians (NRIs) choosing term insurance from India via its platform. This surge is driven by the unparalleled ease, affordability and...

at 02:00
C.K. McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction. After encountering instances of racism and...

at 02:00
OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for March 29, 2024. OKX...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: